Английская Википедия:AN-788

Материал из Онлайн справочника
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Drugbox

AN-788, also known as NSD-788, is an experimental medication which was originated by NeuroSearch and is under development by Aniona and Saniona for the treatment of major depressive disorder.[1][2][3] It was also under development for anxiety disorders, but development for this indication was discontinued.[1] The drug acts as a serotonin–dopamine reuptake inhibitor (SDRI).[1][2][3] As of November of 2018, it is in an agreement for phase II clinical trials for major depressive disorder.[4]

See also

References

Шаблон:Reflist

Шаблон:Monoamine reuptake inhibitors


Шаблон:Nervous-system-drug-stub